NMD4C Early Career Award Nominations Extended

We have extended the nomination submission deadline for our NMD4C Early-Career Investigator Awards! The new deadline is January 13th, 2023.

This initiative will allow NMD4C early-career members to be nominated for one of four awards, celebrating excellence and contribution to the neuromuscular field in both clinical and basic science streams.

The four early-career award categories that will be awarded for 2022 are:

  • Early Career Researcher of the Year (Biomedical)
  • Early Career Researcher of the Year (Clinical)
  • Publication of the Year (Biomedical)
  • Publication of the Year (Clinical)

If you wish to nominate yourself or an individual for any of these awards, please submit the following information via the nomination form here: https://www.surveymonkey.ca/r/NMD4C-ECawards.

You will be asked to include:

  1. Category for which you are nominating the individual.
  2. Brief bio sketch of the nominee. (any kind of biosketch accepted)
  3. Up to three clinical or research milestones of the nominee.
  4. Brief paragraph highlighting the achievements of the individual, and why you think they should receive the award.
  5. (For publication of the year biomedical/clinical) A PDF copy of the full publication you wish to nominate. *Publications from November 2021 – Present will be eligible.

Please complete this nomination form before the deadline of January 13, 2023 at 11:59pm ET.

The awards will be announced in January 2023 alongside the NMD4C/MDC neuromuscular clinical and postdoctoral research fellowships. If you have any questions, please feel free to reach out to communications coordinator James Davis at !

To be eligible for this award you must fall within the CIHR early-career criteria as being within five years of the date of a first independent appointment, and be a member of the NMD4C (if you are not a member, you can sign up here!)

NMD4C launches early career awards for 2022.

Read next...

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy

Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.

LEARNMD content update - February 2025

New Content Available in LEARNMD

LEARNMD is the NMD4C’s online educational platform, offering talks and sessions on a wide range of neuromuscular topics presented by leading clinical and scientific experts worldwide. We’re excited to share what’s new on LEARNMD in February 2025!

RQAS logo

Quebec Network RĂ©seau QuĂ©bĂ©coise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group

We are thrilled to announce that the RQAS, a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy has officially become a sub-group Community of Practice of the NMD4C

2024 year in review

NMD4C 2024 Year in Review

This year in review outlines a collection of achievements from the network over the past year.

2025 NM fellowship funding recipients

NMD4C and MDC Award Fellowship Funding in NMD Research and Medicine

Together the Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are excited to announce the 2025 recipients of our neuromuscular fellowship funding competition to award postdoctoral fellowships in neuromuscular disease (NMD) research and clinical fellowships in neuromuscular medicine and electromyography!

Meet the Basic Science Trainee Committee

NMD4C Basic Science Trainee Committee Provides Leadership Opportunity for Next Generation of Neuromuscular Researchers

The newly-formed Basic Science Trainee Committee represents the interests of trainees within the network, offering an opportunity for professional growth for future leaders in neuromuscular research.